| Name | Sector |
Revenue
$mlns |
M&A Activity | Last 5 Years | ||
|---|---|---|---|---|---|---|
| Total | Buy | Sell | ||||
|
UCB
Public Brussels, Belgium website |
Life Science | 6,933 | 18 | 11 | 7 |
|
|
Galapagos
NASDAQ : GLPG Mechelen, Belgium website |
Life Science | 311 | 13 | 9 | 4 |
|
|
MDxHealth
NASDAQ : MDXH Herstal, Belgium website |
Life Science | 90 | 3 | 3 | - |
|
|
Celyad Oncology
Public Mont-Saint-Guibert, Belgium website |
Life Science | 3 | 2 | 2 | - |
|
|
Bone Therapeutics
Frankfurt (FWB) : BT1 Gosselies, Belgium website |
Life Science | 1 | 2 | 1 | 1 |
|
|
Realco
Public Louvain-la-Neuve, Belgium website |
Life Science | 14 | 1 | - | 1 |
|
|
Oxurion
London Stock Exchange : 0G99 Leuven, Belgium website |
Life Science | 1 | - | - | - |
|
Mergr was built to make it easy to understand who owns which companies — and how they got there.
Whether you're researching private equity-backed businesses, recent acquisitions, or potential targets, Mergr provides structured access to thousands of companies, investors, and ownership histories.
The platform is powerful but easy to use — so you can quickly surface relevant companies and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.